The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The FDA quickly responded, saying it would leave tirzepatide on the list for a period of time as they reevaluated, allowing ...

Weight loss drugs like Wegovy, Ozempic, and Mounjaro show transformative effects in obesity, improving heart health and ...

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

The recall, according to a news release published Wednesday, involves Northwest Naturals' Feline Turkey Recipe raw frozen pet ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

Novo Nordisk and Eli Lilly face soaring demand--and stiff competition--as obesity drug market transforms healthcare and ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Euronews Health looks at some of this year’s top medical advances and the key areas of health that were the most solicited ...

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...